Merck
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merck and other ETFs, options, and stocks.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
MRK News
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook On Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter...
Loading... Loading... U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling by around 250 points on Thursday. The Dow traded down...
Shares of Merck & Company (MRK) are trading higher early Thursday after the pharmaceutical giant posted robust sales results in the first quarter, leading the p...
Analyst ratings
83%
of 29 ratingsMore MRK News
HGTV's Property Brothers react to mortgage rates rising over 7% CC Share Subtitles Off English view video HGTV's Property Brothers react to mortgage rates risi...
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how ris...
For Immediate Release Chicago, IL – April 25, 2024 – Today, Zacks Equity Research discusses Eli Lilly LLY, Novo Nordisk NVO, Merck MRK and AbbVie ABBV. Indust...
By Patrick Wingrove (Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of strong sales for its blockbuster cancer dru...
Shares of Bristol-Myers Squibb dipped in the premarket Thursday even as the company’s Q1 2024 results exceeded expectations amid headwinds to key components in...
Merck (NYSE:MRK) delivered a Q1 earnings beat on Thursday, with reporting adjusted earnings reaching $2.07 per share, compared to $1.40 per share in the same pe...
Merck (NYSE:MRK) shares traded higher premarket Thursday after the pharma giant reported better than expected Q1 2024 financials and raised its full-year outloo...
